Format
Sort by
Items per page

Send to

Choose Destination

Links from Nucleotide

Items: 1 to 20 of 110

1.

Architecture of the human interactome defines protein communities and disease networks.

Huttlin EL, Bruckner RJ, Paulo JA, Cannon JR, Ting L, Baltier K, Colby G, Gebreab F, Gygi MP, Parzen H, Szpyt J, Tam S, Zarraga G, Pontano-Vaites L, Swarup S, White AE, Schweppe DK, Rad R, Erickson BK, Obar RA, Guruharsha KG, Li K, Artavanis-Tsakonas S, Gygi SP, Harper JW.

Nature. 2017 May 25;545(7655):505-509. doi: 10.1038/nature22366. Epub 2017 May 17.

2.

SerpinB3 upregulates the Cyclooxygenase-2 / β-Catenin positive loop in colorectal cancer.

Terrin L, Agostini M, Ruvoletto M, Martini A, Pucciarelli S, Bedin C, Nitti D, Pontisso P.

Oncotarget. 2017 Feb 28;8(9):15732-15743. doi: 10.18632/oncotarget.14997.

3.

Recurrent SERPINB3 and SERPINB4 mutations in patients who respond to anti-CTLA4 immunotherapy.

Riaz N, Havel JJ, Kendall SM, Makarov V, Walsh LA, Desrichard A, Weinhold N, Chan TA.

Nat Genet. 2016 Nov;48(11):1327-1329. doi: 10.1038/ng.3677. Epub 2016 Sep 26.

4.

The Correlation Between the Serum Squamous Carcinoma Antigen and the Prognosis of Recurrent Cervical Squamous Carcinoma.

Wang Y, Cui T, Du L, Xu X, Tian B, Sun T, Han C, Zhao X, Jing J.

J Clin Lab Anal. 2017 Jan;31(1). doi: 10.1002/jcla.22020. Epub 2016 Jul 20.

PMID:
27435426
5.

Evaluation of vaginal fluid squamous cell carcinoma antigen test in diagnosis of premature rupture of membranes.

Koike N, Oi H, Naruse K, Tsunemi T, Akasaka J, Sado T, Kobayashi H.

J Matern Fetal Neonatal Med. 2017 Feb;30(3):334-337. Epub 2016 Apr 19.

PMID:
27095020
6.

Squamous cell carcinoma antigen as a diagnostic marker of nasal inverted papilloma.

Yamashita Y, Uehara T, Hasegawa M, Deng Z, Matayoshi S, Kiyuna A, Kondo S, Maeda H, Ganaha A, Suzuki M.

Am J Rhinol Allergy. 2016 Mar-Apr;30(2):122-7. doi: 10.2500/ajra.2016.30.4287. Epub 2016 Feb 12.

PMID:
26877539
7.

Serum Biomarkers Associated with Clinical Outcomes Fail to Predict Brain Metastases in Patients with Stage IV Non-Small Cell Lung Cancers.

Li BT, Lou E, Hsu M, Yu HA, Naidoo J, Zauderer MG, Sima C, Johnson ML, Daras M, DeAngelis LM, Fleisher M, Kris MG, Azzoli CG.

PLoS One. 2016 Jan 5;11(1):e0146063. doi: 10.1371/journal.pone.0146063. eCollection 2016. Erratum in: PLoS One. 2016;11(3):e0152450.

8.

SerpinB3 and Yap Interplay Increases Myc Oncogenic Activity.

Turato C, Cannito S, Simonato D, Villano G, Morello E, Terrin L, Quarta S, Biasiolo A, Ruvoletto M, Martini A, Fasolato S, Zanus G, Cillo U, Gatta A, Parola M, Pontisso P.

Sci Rep. 2015 Dec 4;5:17701. doi: 10.1038/srep17701.

9.

The scaffold protein KSR1, a novel therapeutic target for the treatment of Merlin-deficient tumors.

Zhou L, Lyons-Rimmer J, Ammoun S, Müller J, Lasonder E, Sharma V, Ercolano E, Hilton D, Taiwo I, Barczyk M, Hanemann CO.

Oncogene. 2016 Jun 30;35(26):3443-53. doi: 10.1038/onc.2015.404. Epub 2015 Nov 9.

10.

Prognostic impact of cytological fluid tumor markers in non-small cell lung cancer.

Cho A, Hur J, Hong YJ, Lee HJ, Kim YJ, Hong SR, Suh YJ, Im DJ, Kim YJ, Lee JS, Shim HS, Choi BW.

Tumour Biol. 2016 Mar;37(3):3205-13. doi: 10.1007/s13277-015-4034-6. Epub 2015 Oct 2.

PMID:
26432331
11.

The Diagnostic and Prognostic Value of Tumor Markers (CEA, SCC, CYFRA 21-1, TPS) in Head and Neck Cancer Patients.

Barak V, Meirovitz A, Leibovici V, Rachmut J, Peretz T, Eliashar R, Gross M.

Anticancer Res. 2015 Oct;35(10):5519-24.

PMID:
26408719
12.

Panorama of ancient metazoan macromolecular complexes.

Wan C, Borgeson B, Phanse S, Tu F, Drew K, Clark G, Xiong X, Kagan O, Kwan J, Bezginov A, Chessman K, Pal S, Cromar G, Papoulas O, Ni Z, Boutz DR, Stoilova S, Havugimana PC, Guo X, Malty RH, Sarov M, Greenblatt J, Babu M, Derry WB, Tillier ER, Wallingford JB, Parkinson J, Marcotte EM, Emili A.

Nature. 2015 Sep 17;525(7569):339-44. doi: 10.1038/nature14877. Epub 2015 Sep 7.

13.

The BioPlex Network: A Systematic Exploration of the Human Interactome.

Huttlin EL, Ting L, Bruckner RJ, Gebreab F, Gygi MP, Szpyt J, Tam S, Zarraga G, Colby G, Baltier K, Dong R, Guarani V, Vaites LP, Ordureau A, Rad R, Erickson BK, Wühr M, Chick J, Zhai B, Kolippakkam D, Mintseris J, Obar RA, Harris T, Artavanis-Tsakonas S, Sowa ME, De Camilli P, Paulo JA, Harper JW, Gygi SP.

Cell. 2015 Jul 16;162(2):425-440. doi: 10.1016/j.cell.2015.06.043.

14.

Quantitative Proteomics Reveals Dynamic Interactions of the Minichromosome Maintenance Complex (MCM) in the Cellular Response to Etoposide Induced DNA Damage.

Drissi R, Dubois ML, Douziech M, Boisvert FM.

Mol Cell Proteomics. 2015 Jul;14(7):2002-13. doi: 10.1074/mcp.M115.048991. Epub 2015 May 11.

15.

Squamous cell carcinoma antigen in hepatocellular carcinoma: Ready for the prime time?

Montagnana M, Danese E, Lippi G.

Clin Chim Acta. 2015 May 20;445:161-6. doi: 10.1016/j.cca.2015.03.031. Epub 2015 Apr 1. Review.

PMID:
25840050
16.

Prognostic significance of serum squamous cell carcinoma antigen in patients with head and neck cancer.

Imai R, Takenaka Y, Yasui T, Nakahara S, Yamamoto Y, Hanamoto A, Takemoto N, Fukusumi T, Cho H, Yamamoto M, Inohara H.

Acta Otolaryngol. 2015 Mar;135(3):295-301. doi: 10.3109/00016489.2014.951454. Epub 2015 Jan 26.

PMID:
25622661
17.

Proteomic analyses reveal distinct chromatin-associated and soluble transcription factor complexes.

Li X, Wang W, Wang J, Malovannaya A, Xi Y, Li W, Guerra R, Hawke DH, Qin J, Chen J.

Mol Syst Biol. 2015 Jan 21;11(1):775. doi: 10.15252/msb.20145504.

18.

Hypoxia up-regulates SERPINB3 through HIF-2α in human liver cancer cells.

Cannito S, Turato C, Paternostro C, Biasiolo A, Colombatto S, Cambieri I, Quarta S, Novo E, Morello E, Villano G, Fasolato S, Musso T, David E, Tusa I, Rovida E, Autelli R, Smedile A, Cillo U, Pontisso P, Parola M.

Oncotarget. 2015 Feb 10;6(4):2206-21.

19.

Evaluation of squamous cell carcinoma antigen-immunoglobulin M complex (SCCA-IGM) and alpha-L-fucosidase (AFU) as novel diagnostic biomarkers for hepatocellular carcinoma.

Mossad NA, Mahmoud EH, Osman EA, Mahmoud SH, Shousha HI.

Tumour Biol. 2014 Nov;35(11):11559-64. doi: 10.1007/s13277-014-2467-y. Epub 2014 Aug 17.

PMID:
25129443
20.

SERPINB3/B4 contributes to early inflammation and barrier dysfunction in an experimental murine model of atopic dermatitis.

Sivaprasad U, Kinker KG, Ericksen MB, Lindsey M, Gibson AM, Bass SA, Hershey NS, Deng J, Medvedovic M, Khurana Hershey GK.

J Invest Dermatol. 2015 Jan;135(1):160-169. doi: 10.1038/jid.2014.353. Epub 2014 Aug 11.

Supplemental Content

Support Center